Skip to content
10-Q

Quarterly Report

INTELLIA THERAPEUTICS, INC. NTLA

0001193125-25-269680

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 115.83M sh
Shares Diluted Q3 2025 · Sep 30, 2025 110.19M sh
Shares Diluted Q3 2025 · Sep 30, 2025 105.84M sh
Shares Diluted Q3 2025 · Sep 30, 2024 101M sh
Shares Diluted Q3 2025 · Sep 30, 2024 97.84M sh
Capex Q3 2025 · Sep 30, 2025 $1M
Capex Q3 2025 · Sep 30, 2024 $4.8M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$325.45M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$263.69M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $193.39M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $189.18M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $120.5M
Stockholders Equity Q3 2025 · Sep 30, 2025 $748.42M
Stockholders Equity Q3 2025 · Jun 30, 2025 $715.26M
Stockholders Equity Q3 2025 · Mar 31, 2025 $779.92M
Stockholders Equity Q3 2025 · Dec 31, 2024 $871.96M
Stockholders Equity Q3 2025 · Sep 30, 2024 $962.62M
Stockholders Equity Q3 2025 · Jun 30, 2024 $971.06M
Stockholders Equity Q3 2025 · Mar 31, 2024 $1.04B
Stockholders Equity Q3 2025 · Dec 31, 2023 $1.05B
Current Liabilities Q3 2025 · Sep 30, 2025 $93.73M
Current Liabilities Q3 2025 · Dec 31, 2024 $110.85M
Total Liabilities Q3 2025 · Sep 30, 2025 $176.85M
Total Liabilities Q3 2025 · Dec 31, 2024 $319.06M
Current Assets Q3 2025 · Sep 30, 2025 $581.94M
Current Assets Q3 2025 · Dec 31, 2024 $639.86M
Total Assets Q3 2025 · Sep 30, 2025 $925.28M
Total Assets Q3 2025 · Dec 31, 2024 $1.19B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.92
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.99
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.34
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.99
Eps Basic Q3 2025 · Sep 30, 2025 −$0.92
Eps Basic Q3 2025 · Sep 30, 2025 −$2.99
Eps Basic Q3 2025 · Sep 30, 2024 −$1.34
Eps Basic Q3 2025 · Sep 30, 2024 −$3.99
Sga Expense Q3 2025 · Sep 30, 2025 $30.51M
Sga Expense Q3 2025 · Sep 30, 2025 $86.73M
Sga Expense Q3 2025 · Sep 30, 2024 $30.5M
Sga Expense Q3 2025 · Sep 30, 2024 $93.39M
Rd Expense Q3 2025 · Sep 30, 2025 $94.75M
Rd Expense Q3 2025 · Sep 30, 2025 $300.21M
Rd Expense Q3 2025 · Sep 30, 2024 $123.38M
Rd Expense Q3 2025 · Sep 30, 2024 $349.43M
Net Income Q3 2025 · Sep 30, 2025 −$101.32M
Net Income Q3 2025 · Sep 30, 2025 −$316.91M
Net Income Q3 2025 · Jun 30, 2025 −$101.26M
Net Income Q3 2025 · Mar 31, 2025 −$114.33M
Net Income Q3 2025 · Sep 30, 2024 −$135.71M
Net Income Q3 2025 · Sep 30, 2024 −$390.12M
Net Income Q3 2025 · Jun 30, 2024 −$146.98M
Net Income Q3 2025 · Mar 31, 2024 −$107.44M
Operating Income Q3 2025 · Sep 30, 2025 −$111.48M
Operating Income Q3 2025 · Sep 30, 2025 −$342.28M
Operating Income Q3 2025 · Sep 30, 2024 −$144.77M
Operating Income Q3 2025 · Sep 30, 2024 −$397.82M
Revenue Q3 2025 · Sep 30, 2025 $13.78M
Revenue Q3 2025 · Sep 30, 2025 $44.65M
Revenue Q3 2025 · Sep 30, 2024 $9.11M
Revenue Q3 2025 · Sep 30, 2024 $45M